Allosteric rescuing of loss-of-function FFAR2 mutations

FEBS Lett. 2010 Oct 8;584(19):4208-14. doi: 10.1016/j.febslet.2010.09.007. Epub 2010 Sep 17.

Abstract

FFAR2 (GPR43) is a receptor for short-chain fatty acids (SCFAs), acetate and propionate. In the current study, we investigate the molecular determinants contributing to receptor activation by endogenous ligands. Mutational analysis revealed several important residues located in transmembrane domains (TM) 3, 4, 5, 6, and 7 for acetate binding. Interestingly, mutations that abolished acetate activity, including the mutation in the well-conserved D(E)RY motif, could be rescued by a recently identified synthetic allosteric agonist. These findings provide additional insight into agonist binding and activation which may aid in designing allosteric ligands for targeting receptor function in various diseases.

MeSH terms

  • Acetamides / pharmacology
  • Acetic Acid / metabolism
  • Allosteric Regulation
  • Allosteric Site / genetics
  • Amino Acid Motifs
  • Humans
  • In Vitro Techniques
  • Kinetics
  • Ligands
  • Models, Molecular
  • Mutagenesis, Site-Directed
  • Mutant Proteins / agonists
  • Mutant Proteins / chemistry
  • Mutant Proteins / genetics
  • Mutant Proteins / metabolism
  • Receptors, Cell Surface / agonists
  • Receptors, Cell Surface / chemistry*
  • Receptors, Cell Surface / genetics*
  • Receptors, Cell Surface / metabolism
  • Recombinant Proteins / agonists
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism

Substances

  • Acetamides
  • FFA2R protein, human
  • Ligands
  • Mutant Proteins
  • Receptors, Cell Surface
  • Recombinant Proteins
  • Acetic Acid